OBJECTIVE: We sought to quantify clinical decision points for identifying depression treatment nonremitters prior to end-of-treatment. METHOD: Data came from the psychotherapy arms of a randomized clinical trial for chronic depression. Participants (n = 352; 65.6% female; 92.3% White; mean age = 44.3 years) received 12 weeks of cognitive behavioral analysis system of psychotherapy (CBASP) or CBASP plus an antidepressant medication. In half of the sample, receiver operating curve analyses were used to identify efficient percentage of symptom reduction cut points on the Inventory of Depressive Symptoms-Self-Report (IDS-SR) for predicting end-of-treatment nonremission based on the Hamilton Rating Scale for Depression (HRSD). Sensitivity, specificity, predictive values, and Cohen's kappa for identified cut points were calculated using the remaining half of the sample. RESULTS:Percentage of IDS-SR symptom reduction at Weeks 6 and 8 predicted end-of-treatment HRSD remission status in both the combined treatment (Week 6 cut point = 50.0%, Cohen's κ = .42; Week 8 cut point = 54.3%, Cohen's κ = .45) and psychotherapy only (Week 6 cut point = 60.7%, Cohen's κ = .41; Week 8 cut point = 48.7%, Cohen's κ = .49). Status at Week 8 was more reliable for identifying nonremitters in psychotherapy-only treatment. CONCLUSIONS: Those with chronic depression who will not remit in structured, time-limited psychotherapy for depression, either with therapy alone or in combination with antidepressant medication, are identifiable prior to end of treatment. Findings provide an operationalized strategy for designing adaptive psychotherapy interventions.
RCT Entities:
OBJECTIVE: We sought to quantify clinical decision points for identifying depression treatment nonremitters prior to end-of-treatment. METHOD: Data came from the psychotherapy arms of a randomized clinical trial for chronic depression. Participants (n = 352; 65.6% female; 92.3% White; mean age = 44.3 years) received 12 weeks of cognitive behavioral analysis system of psychotherapy (CBASP) or CBASP plus an antidepressant medication. In half of the sample, receiver operating curve analyses were used to identify efficient percentage of symptom reduction cut points on the Inventory of Depressive Symptoms-Self-Report (IDS-SR) for predicting end-of-treatment nonremission based on the Hamilton Rating Scale for Depression (HRSD). Sensitivity, specificity, predictive values, and Cohen's kappa for identified cut points were calculated using the remaining half of the sample. RESULTS: Percentage of IDS-SR symptom reduction at Weeks 6 and 8 predicted end-of-treatment HRSD remission status in both the combined treatment (Week 6 cut point = 50.0%, Cohen's κ = .42; Week 8 cut point = 54.3%, Cohen's κ = .45) and psychotherapy only (Week 6 cut point = 60.7%, Cohen's κ = .41; Week 8 cut point = 48.7%, Cohen's κ = .49). Status at Week 8 was more reliable for identifying nonremitters in psychotherapy-only treatment. CONCLUSIONS: Those with chronic depression who will not remit in structured, time-limited psychotherapy for depression, either with therapy alone or in combination with antidepressant medication, are identifiable prior to end of treatment. Findings provide an operationalized strategy for designing adaptive psychotherapy interventions.
Authors: Corinne Hannan; Michael J Lambert; Cory Harmon; Stevan Lars Nielsen; David W Smart; Kenichi Shimokawa; Scott W Sutton Journal: J Clin Psychol Date: 2005-02
Authors: Daniel Almirall; Scott N Compton; Meredith Gunlicks-Stoessel; Naihua Duan; Susan A Murphy Journal: Stat Med Date: 2012-03-22 Impact factor: 2.373
Authors: Christopher Kratochvil; Graham Emslie; Susan Silva; Steve McNulty; John Walkup; John Curry; Mark Reinecke; Benedetto Vitiello; Paul Rohde; Nora Feeny; Charles Casat; Sanjeev Pathak; Elizabeth Weller; Diane May; Taryn Mayes; Michele Robins; John March Journal: J Am Acad Child Adolesc Psychiatry Date: 2006-12 Impact factor: 8.829
Authors: M M Biggs; K Shores-Wilson; A J Rush; T J Carmody; M H Trivedi; M L Crismon; M G Toprac; M Mason Journal: Psychiatry Res Date: 2000-11-20 Impact factor: 3.222
Authors: Rachel Manber; Helena C Kraemer; Bruce A Arnow; Madhukar H Trivedi; A John Rush; Michael E Thase; Barbara O Rothbaum; Daniel N Klein; James H Kocsis; Alan J Gelenberg; Martin E Keller Journal: J Consult Clin Psychol Date: 2008-06
Authors: Meredith Gunlicks-Stoessel; Laura Mufson; Ana Westervelt; Daniel Almirall; Susan Murphy Journal: J Clin Child Adolesc Psychol Date: 2015-03-18
Authors: Stephen M Schueller; Mary J Kwasny; Blake F Dear; Nickolai Titov; David C Mohr Journal: Gen Hosp Psychiatry Date: 2015-05-29 Impact factor: 3.238
Authors: John J Dziak; Donna L Coffman; Matthew Reimherr; Justin Petrovich; Runze Li; Saul Shiffman; Mariya P Shiyko Journal: Stat Surv Date: 2019-11-06